<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>爱学习的小眠 | wechat-feeds</title><link>http://MzUxNjExODc4MA.favicon.privacyhide.com/favicon.ico</link><description>一起做爱学习的医药人</description><managingEditor> (hellodword)</managingEditor><pubDate>Mon, 25 Jan 2021 23:47:41 +0800</pubDate><image><url>http://MzUxNjExODc4MA.favicon.privacyhide.com/favicon.ico</url><title>爱学习的小眠 | wechat-feeds</title><link>http://MzUxNjExODc4MA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>新法规下仿制药最早什么时候能申报上市</title><link>https://mp.weixin.qq.com/s/IlCvy6Cw-nh6uSKyhuwejA</link><description></description><content:encoded><![CDATA[新法规下仿制药最早什么时候能申报上市]]></content:encoded><pubDate>Sun, 05 Jul 2020 01:34:49 +0800</pubDate></item><item><title>美国首仿PIV挑战策略</title><link>https://mp.weixin.qq.com/s/Q-ne5ikoJ1EtZ_fKUQTt8A</link><description></description><content:encoded><![CDATA[美国首仿PIV挑战策略]]></content:encoded><pubDate>Sun, 05 Jul 2020 01:34:49 +0800</pubDate></item><item><title>药品注册监管简史</title><link>https://mp.weixin.qq.com/s/GclDsvrWQ160aj_nDixA2w</link><description></description><content:encoded><![CDATA[药品注册监管简史]]></content:encoded><pubDate>Sat, 04 Jul 2020 18:35:19 +0800</pubDate></item><item><title>美国十大制药企业</title><link>https://mp.weixin.qq.com/s/IpUtXD3MlNYJoUl1zpDP4Q</link><description></description><content:encoded><![CDATA[美国十大制药企业]]></content:encoded><pubDate>Thu, 27 Jul 2017 09:56:23 +0800</pubDate></item><item><title>BizVibe公布中国十大制药企业</title><link>https://mp.weixin.qq.com/s/bfDxO41al0SxL3JCNiOong</link><description></description><content:encoded><![CDATA[BizVibe公布中国十大制药企业]]></content:encoded><pubDate>Wed, 26 Jul 2017 11:49:33 +0800</pubDate></item><item><title>PI3Kδ/γ双靶点抑制剂duvelisib的上市之路还要多长？</title><link>https://mp.weixin.qq.com/s/LIRSeLT8eox7DKDAxn1lRA</link><description></description><content:encoded><![CDATA[PI3Kδ/γ双靶点抑制剂duvelisib的上市之路还要多长？]]></content:encoded><pubDate>Mon, 26 Jun 2017 14:10:15 +0800</pubDate></item><item><title>原创 | 葛兰素基因疗法Strimvelis开张</title><link>https://mp.weixin.qq.com/s/b3Bb7L06CdZzng_8OVO4mw</link><description></description><content:encoded><![CDATA[原创 | 葛兰素基因疗法Strimvelis开张]]></content:encoded><pubDate>Fri, 23 Jun 2017 13:21:22 +0800</pubDate></item><item><title>抗体偶联药物概览</title><link>https://mp.weixin.qq.com/s/8Let2mTiD2sb6Hxy8GsE8g</link><description></description><content:encoded><![CDATA[抗体偶联药物概览]]></content:encoded><pubDate>Thu, 22 Jun 2017 12:02:01 +0800</pubDate></item><item><title>新申报临床1类新药ICP-022和BR61501</title><link>https://mp.weixin.qq.com/s/pUXNnyGz_LzFYl4Xb7eOdA</link><description></description><content:encoded><![CDATA[新申报临床1类新药ICP-022和BR61501]]></content:encoded><pubDate>Thu, 22 Jun 2017 12:02:01 +0800</pubDate></item><item><title>FDA批准新药delafloxacin上市</title><link>https://mp.weixin.qq.com/s/UL3_p4_Kz4yIm-DrYLquSA</link><description></description><content:encoded><![CDATA[FDA批准新药delafloxacin上市]]></content:encoded><pubDate>Tue, 20 Jun 2017 11:06:07 +0800</pubDate></item><item><title>科伦药业1.1类新药KL100137速览</title><link>https://mp.weixin.qq.com/s/GPyN4WG2ZByYj7LUf14VBg</link><description></description><content:encoded><![CDATA[科伦药业1.1类新药KL100137速览]]></content:encoded><pubDate>Mon, 19 Jun 2017 10:26:16 +0800</pubDate></item><item><title>重庆文理学院申请的1类新药DDCI-01是何方神圣？</title><link>https://mp.weixin.qq.com/s/oD46zwPStuHaB8p02Ptr5w</link><description></description><content:encoded><![CDATA[重庆文理学院申请的1类新药DDCI-01是何方神圣？]]></content:encoded><pubDate>Fri, 16 Jun 2017 09:53:13 +0800</pubDate></item></channel></rss>